William Fairey

Insider Reports History

Entity
Individual
Location
C/O Chemocentryx, Inc., 850 Maude Ave., Mountain View, CA
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Fairey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirum Pharmaceuticals, Inc. Director Restricted Stock Units 5.7K $120K $21.05 Jun 5, 2024 Direct
KalVista Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 10K Oct 3, 2024 Direct
Mirum Pharmaceuticals, Inc. Director Stock Option (right to buy) 8.78K Jun 5, 2024 Direct
Aileron Therapeutics, Inc. Director Stock Option (right to buy) 2.73K Aug 20, 2024 Direct

Insider Reports Filed by William Fairey

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Oct 3, 2024 1 $0 4 Oct 4, 2024 Director
ALRN Aileron Therapeutics, Inc. Aug 20, 2024 1 $0 4 Aug 22, 2024 Director
MIRM Mirum Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
KALV KalVista Pharmaceuticals, Inc. Apr 18, 2024 1 $0 4 Apr 22, 2024 Director
KALV KalVista Pharmaceuticals, Inc. Apr 18, 2024 0 $0 3 Apr 22, 2024 Director
ALRN AILERON THERAPEUTICS INC Oct 31, 2023 1 $0 4 Nov 2, 2023 Director
ALRN AILERON THERAPEUTICS INC Oct 31, 2023 0 $0 3 Nov 2, 2023 Director
MIRM Mirum Pharmaceuticals, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
MIRM Mirum Pharmaceuticals, Inc. Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
MIRM Mirum Pharmaceuticals, Inc. Aug 19, 2021 1 $0 4 Aug 20, 2021 Director
MIRM Mirum Pharmaceuticals, Inc. Aug 19, 2021 0 $0 3 Aug 20, 2021 Director